SCHEMBL4049003

SCHEMBL4049003

CNCC(O)c1cccc(Br)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 5/20 0.67
HIF1A Q16665 4/20 0.67
ADRB2 P07550 3/20 0.67
ADRB1 P08588 3/20 0.67
ADRA2A P08913 3/20 0.67
ADRB3 P13945 3/20 0.67
ADRA2B P18089 3/20 0.67
ADRA2C P18825 3/20 0.67
TSHR P16473 2/20 0.67
DRD1 P21728 2/20 0.67
ADRA1A P35348 2/20 0.67
ADRA1B P35368 2/20 0.67
DRD3 P35462 2/20 0.67
HTR1A P08908 2/20 0.67
NFKB1 P19838 1/20 0.67
HTR7 P34969 1/20 0.67
RAB9A P51151 1/20 0.67
KDM4E B2RXH2 4/20 0.65
BLM P54132 3/20 0.65
LMNA P02545 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10193677 0.82 SLC6A3 (0.46) SLC6A3HIF1AADRB2ADRB1ADRA2A
SCHEMBL19789444 0.80 NPC1 (0.49) SLC6A3HIF1AADRB2ADRB1ADRA2A
SCHEMBL5848382 0.80 HIF1A (0.53) SLC6A3HIF1AADRB2ADRB1ADRA2A
Phenylephrine SCHEMBL29382851 0.80 HIF1A (1.00) SLC6A3HIF1AADRB2ADRB1ADRA2A
SCHEMBL3442993 0.80 HIF1A (0.69) SLC6A3HIF1AADRB2ADRB1ADRA2A
SCHEMBL16072431 0.80 HIF1A (0.69) SLC6A3HIF1AADRB2ADRB1ADRA2A
Phenylephrine SCHEMBL29392606 0.80 HIF1A (1.00) SLC6A3HIF1AADRB2ADRB1ADRA2A
Phenylephrine SCHEMBL4711 0.80 HIF1A (1.00) SLC6A3HIF1AADRB2ADRB1ADRA2A
Phenylephrine SCHEMBL4712 0.80 HIF1A (1.00) SLC6A3HIF1AADRB2ADRB1ADRA2A
Phenylephrine SCHEMBL895602 0.80 HIF1A (1.00) SLC6A3HIF1AADRB2ADRB1ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1758585-A4 HIV INTEGRASE INHIBITORS MERCK & CO INC (US) 2009-07-22 EP disclosed
US-7476666-B2 HIV integrase inhibitors MERCK & CO., INC. (US) 2009-01-13 US disclosed
CN-101146540-A HIV integrase inhibitors MERCK & CO INC (US) 2008-03-19 CN disclosed
US-20080015187-A1 Hiv Integrase Inhibitors MERCK SHARP & DOHME CORP. 2008-01-17 US disclosed
EP-1758585-A2 HIV INTEGRASE INHIBITORS Merck & Co., Inc. (US) 2007-03-07 EP disclosed
US-7112605-B2 Sulfonyl-containing 3,4-diaryl-3-pyrrolin-2-ones, preparation method, and medical use thereof Research Institute of Materia Medica Chinese Acadamy of Medical Sciences (CN) 2006-09-26 US disclosed
WO-2005120516-A2 HIV INTEGRASE INHIBITORS MERCK & CO., INC. (US) 2005-12-22 WO disclosed
US-20040029951-A1 Sulfonyl-containing 3,4-diaryl-3-pyrrolin-2-ones, preparation method, and medical use thereof RESEARCH INSTITUTE OF MATERIAL MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES; 2004-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040029951-A1 Sulfonyl-containing 3,4-diaryl-3-pyrrolin-2-ones, preparation method, and medical use thereof PTGS1, PTGS2, PTGER1 SLC6A3 1584/4885HIF1A 719/4885ADRB2 768/4885
US-20080015187-A1 Hiv Integrase Inhibitors REV1, ZC3HAV1, PNP SLC6A3 4241/4885HIF1A 4255/4885ADRB2 2280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.